USMLE Forum Archives - USMLE Step 2 CK - DYSLIPIDEMIA
DYSLIPIDEMIA
sudha2015 - 02-22-11 10:18
According to a recent randomized, single-blind, placebo-controlled, cross-over study comparing fenobirate therapy with placebo in patients with primary hypertriglyceridemia, which of the following results is NOT true?
1. Fenobirate therapy increased plasma levels of TNF-a and hsCRP
2. Fenobirate therapy increased insulin sensitivity
3. Fenobirate therapy increased plasma levels of adiponectin
. 4 Fenobirate therapy decreased plasma levels of leptin and resistin
sudha2015 - 02-22-11 10:18
According to a recent randomized, single-blind, placebo-controlled, cross-over study comparing fenobirate therapy with placebo in patients with primary hypertriglyceridemia, which of the following results is NOT true?
1. Fenobirate therapy increased plasma levels of TNF-a and hsCRP
2. Fenobirate therapy increased insulin sensitivity
3. Fenobirate therapy increased plasma levels of adiponectin
. 4 Fenobirate therapy decreased plasma levels of leptin and resistin
Page 1
#1
Re: DYSLIPIDEMIA drspleen - 03-12-11 08:27 Fenobirate therapy increased plasma levels of adiponectin
#2
Re: DYSLIPIDEMIA babbu5508 - 03-16-11 16:57 fenofibrate it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing tryglycerides level.
Page 1